All stented patients with atrial fibrillation, stable one year after intervention, should be managed with oral anticoagulants: Chairpersons conclusion.
Topic:
Acute Coronary Syndromes: Post-Infarction Period
Congress Presentation
9 more presentations in this session
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal PRO.
Speaker: Doctor A. Rubboli (Ravenna, IT)
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough - Rebuttal CONTRA.
Speaker: Professor R. Storey (Sheffield, GB)
Low dose of rivaroxaban is a significant achievement for post-MI patients with atherosclerosis. Antiplatelets alone are not enough: Chairpersons conclusion
Access the full session
Controversies on anticoagulants post-MI antithrombotic treatment
Speakers:
Doctor A. Rubboli, Professor R. Storey, Doctor A. Rubboli, Professor R. Storey
About the event
ESC 365 is supported by
